Published in Thromb Haemost on July 01, 2001
Human CD133+ progenitor cells promote the healing of diabetic ischemic ulcers by paracrine stimulation of angiogenesis and activation of Wnt signaling. Circ Res (2009) 3.25
Inflammatory macrophage migration requires MMP-9 activation by plasminogen in mice. J Clin Invest (2008) 2.16
Intracranial and abdominal aortic aneurysms: similarities, differences, and need for a new class of computational models. Annu Rev Biomed Eng (2008) 2.00
Unraveling insulin-like growth factor binding protein-3 actions in human disease. Endocr Rev (2009) 1.76
Imatinib disrupts lymphoma angiogenesis by targeting vascular pericytes. Blood (2013) 1.48
Plasminogen regulates cardiac repair after myocardial infarction through its noncanonical function in stem cell homing to the infarcted heart. J Am Coll Cardiol (2014) 1.45
Transforming growth factor-beta signaling in thoracic aortic aneurysm development: a paradox in pathogenesis. J Vasc Res (2008) 1.42
Molecular imaging of activated matrix metalloproteinases in vascular remodeling. Circulation (2008) 1.37
Oxidative stress, plasminogen activator inhibitor 1, and lung fibrosis. Antioxid Redox Signal (2008) 1.31
Annexin A2 promotes glioma cell invasion and tumor progression. J Neurosci (2011) 1.23
Matrix metalloproteinases and blood-brain barrier disruption in acute ischemic stroke. Front Neurol (2013) 1.23
Expression of matrix metalloproteinase-9 in human platelets: regulation of platelet activation in in vitro and in vivo studies. Br J Pharmacol (2004) 1.13
Immunogenic and plasminogen-binding surface-associated alpha-enolase of Trichomonas vaginalis. Infect Immun (2007) 1.11
Acute endotoxin-induced thymic atrophy is characterized by intrathymic inflammatory and wound healing responses. PLoS One (2011) 1.10
Blood coagulation and the risk of atherothrombosis: a complex relationship. Thromb J (2004) 1.10
Homocysteine inhibits neoangiogenesis in mice through blockade of annexin A2-dependent fibrinolysis. J Clin Invest (2009) 1.04
Fibrinolytic cross-talk: a new mechanism for plasmin formation. Blood (2009) 1.01
The Kunitz-like modulatory protein haemangin is vital for hard tick blood-feeding success. PLoS Pathog (2009) 0.99
Sulfated, low-molecular-weight lignins are potent inhibitorsof plasmin, in addition to thrombin and factor Xa: Novel opportunity for controlling complex pathologies. Thromb Haemost (2009) 0.97
Hyperglycemia modulates plasminogen activator inhibitor-1 expression and aortic diameter in experimental aortic aneurysm disease. Surgery (2010) 0.97
Remodeling of intramural thrombus and collagen in an Ang-II infusion ApoE-/- model of dissecting aortic aneurysms. Thromb Res (2012) 0.95
Haemostatic system in inflammatory bowel diseases: new players in gut inflammation. World J Gastroenterol (2011) 0.95
Increased expression of urokinase during atherosclerotic lesion development causes arterial constriction and lumen loss, and accelerates lesion growth. Proc Natl Acad Sci U S A (2002) 0.95
Plasminogen activation: a mediator of vascular smooth muscle cell apoptosis in atherosclerotic plaques. J Thromb Haemost (2006) 0.94
Macrophage β2 integrin-mediated, HuR-dependent stabilization of angiogenic factor-encoding mRNAs in inflammatory angiogenesis. Am J Pathol (2012) 0.93
The fibrinolytic system in dissemination and matrix protein deposition during a mycobacterium infection. Am J Pathol (2003) 0.93
Plasminogen regulates stromal cell-derived factor-1/CXCR4-mediated hematopoietic stem cell mobilization by activation of matrix metalloproteinase-9. Arterioscler Thromb Vasc Biol (2011) 0.92
Proteolysis of CCN1 by plasmin: functional implications. Cancer Res (2005) 0.91
The vitronectin-binding function of PAI-1 exacerbates lung fibrosis in mice. Blood (2011) 0.90
Porphyromonas gingivalis promotes invasion of oral squamous cell carcinoma through induction of proMMP9 and its activation. Cell Microbiol (2013) 0.90
Increased expression of the urokinase plasminogen activator system by Helicobacter pylori in gastric epithelial cells. Am J Physiol Gastrointest Liver Physiol (2008) 0.89
Transmural intestinal wall permeability in severe ischemia after enteral protease inhibition. PLoS One (2014) 0.89
A novel mechanism of plasmin-induced mitogenesis in fibroblasts. J Thromb Haemost (2005) 0.89
Mechanisms of urokinase plasminogen activator (uPA)-mediated atherosclerosis: role of the uPA receptor and S100A8/A9 proteins. J Biol Chem (2011) 0.88
Overexpression of urokinase by plaque macrophages causes histological features of plaque rupture and increases vascular matrix metalloproteinase activity in aged apolipoprotein e-null mice. Circulation (2010) 0.88
Plasminogen activator inhibitor-1 impairs plasminogen activation-mediated vascular smooth muscle cell apoptosis. Thromb Haemost (2006) 0.87
Plasmin enhances cell surface tissue factor activity in mesothelial and endothelial cells. J Thromb Haemost (2008) 0.86
Noncovalent interaction of alpha(2)-antiplasmin with fibrin(ogen): localization of alpha(2)-antiplasmin-binding sites. Biochemistry (2010) 0.86
The NuRD chromatin-remodeling enzyme CHD4 promotes embryonic vascular integrity by transcriptionally regulating extracellular matrix proteolysis. PLoS Genet (2013) 0.86
Aldosterone, but not angiotensin II, increases profibrotic factors in kidney of adrenalectomized stroke-prone spontaneously hypertensive rats. Am J Physiol Endocrinol Metab (2008) 0.85
Heat shock proteins: pathogenic role in atherosclerosis and potential therapeutic implications. Autoimmune Dis (2012) 0.84
Serase-1B, a new splice variant of polyserase-1/TMPRSS9, activates urokinase-type plasminogen activator and the proteolytic activation is negatively regulated by glycosaminoglycans. Biochem J (2006) 0.83
Paracrine SLPI secretion upregulates MMP-9 transcription and secretion in ovarian cancer cells. Gynecol Oncol (2011) 0.82
Thrombosis in inflammatory bowel diseases: what's the link? Thromb J (2015) 0.82
Plasminogen activation by staphylokinase enhances local spreading of S. aureus in skin infections. BMC Microbiol (2014) 0.81
Liberation of desmosine and isodesmosine as amino acids from insoluble elastin by elastolytic proteases. Biochem Biophys Res Commun (2011) 0.81
Methylophiopogonanone A Protects against Cerebral Ischemia/Reperfusion Injury and Attenuates Blood-Brain Barrier Disruption In Vitro. PLoS One (2015) 0.81
Analysis of MMP2 promoter polymorphisms in childhood obesity. BMC Res Notes (2011) 0.81
Dipeptidyl peptidase-4 inhibitor decreases abdominal aortic aneurysm formation through GLP-1-dependent monocytic activity in mice. PLoS One (2015) 0.81
Regulated expression of matrix metalloproteinases, inflammatory mediators, and endometrial matrix remodeling by 17beta-estradiol in the immature rat uterus. Reprod Biol Endocrinol (2009) 0.81
The plasminogen system in regulating stem cell mobilization. J Biomed Biotechnol (2012) 0.81
Plasminogen is a joint-specific positive or negative determinant of arthritis pathogenesis in mice. Arthritis Rheumatol (2014) 0.81
Case series of post-thrombolysis patients undergoing hemicraniectomy for malignant anterior circulation ischaemic stroke. Cardiovasc Psychiatry Neurol (2011) 0.80
A Review of the Mechanisms of Blood-Brain Barrier Permeability by Tissue-Type Plasminogen Activator Treatment for Cerebral Ischemia. Front Cell Neurosci (2016) 0.80
Enolase, a plasminogen receptor isolated from salivary gland transcriptome of the ixodid tick Haemaphysalis flava. Parasitol Res (2016) 0.80
Curcumin suppresses tumor necrosis factor-α-induced matrix metalloproteinase-2 expression and activity in rat vascular smooth muscle cells via the NF-κB pathway. Exp Ther Med (2014) 0.78
Does plasmin have anticoagulant activity? Vasc Health Risk Manag (2010) 0.78
Steady states and dynamics of urokinase-mediated plasmin activation in silico and in vitro. Biophys J (2011) 0.78
Acute coronary disease Athero-Inflammation: Therapeutic approach. Thromb J (2003) 0.78
Heat shock protein 90 inhibition by 17-Dimethylaminoethylamino-17-demethoxygeldanamycin protects blood-brain barrier integrity in cerebral ischemic stroke. Am J Transl Res (2015) 0.78
Molecular mechanism of the inhibition effect of Lipoxin A4 on corneal dissolving pathology process. Int J Ophthalmol (2013) 0.77
Mitochondrial mitophagic mechanisms of myocardial matrix metabolism and remodelling. Arch Physiol Biochem (2011) 0.77
This is not Dr. Conn's aldosterone anymore. Trans Am Clin Climatol Assoc (2011) 0.77
Molecular mechanism of the inhibition effect of Celecoxib on corneal collagen degradation in three dimensions. Int J Ophthalmol (2012) 0.77
Correlations between serum inflammation factors and left ventricular remodeling in acute ST segment elevation myocardial infarction. Yonsei Med J (2012) 0.77
Monocyte-derived factors including PLA2G7 induced by macrophage-nasopharyngeal carcinoma cell interaction promote tumor cell invasiveness. Oncotarget (2016) 0.76
Inhibition of Thrombin-Activated Fibrinolysis Inhibitor Increases Survival in Experimental Kidney Fibrosis. J Am Soc Nephrol (2014) 0.76
Matrix metalloproteinases production in malignant pleural effusions after talc pleurodesis. Clin Exp Immunol (2003) 0.75
Inhibition of Pterygium Fibroblast Migration and Outgrowth by Bevacizumab and Cyclosporine A Involves Down-Regulation of Matrix Metalloproteinases-3 and -13. PLoS One (2017) 0.75
Elevated Expression of Matrix Metalloproteinase-9 not Matrix Metalloproteinase-2 Contributes to Progression of Extracranial Arteriovenous Malformation. Sci Rep (2016) 0.75
The Tissue Fibrinolytic System Contributes to the Induction of Macrophage Function and CCL3 during Bone Repair in Mice. PLoS One (2015) 0.75
Novel network biomarkers profile based coronary artery disease risk stratification in Asian Indians. Adv Biomed Res (2013) 0.75
Cell surface protease activation during RAS transformation: Critical role of the plasminogen receptor, S100A10. Oncotarget (2016) 0.75
Differential Gene Expression in Coiled versus Flow-Diverter-Treated Aneurysms: RNA Sequencing Analysis in a Rabbit Aneurysm Model. AJNR Am J Neuroradiol (2015) 0.75
Increased expression of phosphorylated forms of heat-shock protein-27 and p38MAPK in macrophage-rich regions of fibro-fatty atherosclerotic lesions in the rabbit. Int J Exp Pathol (2016) 0.75
Synthesis and biological characterization of protease-activated prodrugs of doxazolidine. J Med Chem (2012) 0.75
The Influence of Differentially Expressed Tissue-Type Plasminogen Activator in Experimental Autoimmune Encephalomyelitis: Implications for Multiple Sclerosis. PLoS One (2016) 0.75
Purification and characterization of tenerplasminin-1, a serine peptidase inhibitor with antiplasmin activity from the coral snake (Micrurus tener tener) venom. Comp Biochem Physiol C Toxicol Pharmacol (2015) 0.75
Profile of Metalloproteinases and Their Association with Inflammatory Markers in Pleural Effusions. Lung (2016) 0.75
Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes. Arterioscler Thromb Vasc Biol (1998) 1.48
Neointima formation and thrombosis after vascular injury in transgenic mice overexpressing plasminogen activator inhibitor-1 (PAI-1). J Thromb Haemost (2004) 1.45
Elements of the fibrinolytic system. Ann N Y Acad Sci (2001) 1.21
Generation of an angiostatin-like fragment from plasminogen by stromelysin-1 (MMP-3). Biochemistry (1998) 1.02
Adipose tissue expression of gelatinases in mouse models of obesity. Thromb Haemost (2001) 0.96
Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system. Thromb Haemost (1998) 0.92
Matrix metalloproteinase system deficiencies and matrix degradation. Thromb Haemost (1999) 0.89
Characterization of the murine plasminogen/urokinase-type plasminogen-activator system. Eur J Biochem (1996) 0.88
Tissue inhibitor of matrix metalloproteinases-1 impairs arterial neointima formation after vascular injury in mice. Circ Res (2000) 0.86
Temporal and topographic matrix metalloproteinase expression after vascular injury in mice. Thromb Haemost (1999) 0.84
Plasminogen-dependent and -independent proteolytic activity of murine endothelioma cells with targeted inactivation of fibrinolytic genes. Thromb Haemost (1997) 0.81
CD9 gene deficiency does not affect smooth muscle cell migration and neointima formation after vascular injury in mice. Thromb Haemost (2000) 0.78
Molecular basis of thrombolytic therapy. J Nucl Cardiol (2000) 0.75